Coverage
-
June 25, 2021
A Pennsylvania federal judge raised questions on Friday over whether a whistleblower lawsuit accusing Gilead Sciences Inc. of paying kickbacks to doctors to help boost prescriptions of its Hepatitis C drugs barred a second suit filed months later raising similar allegations about two different drugs.
5 other articles on this case.
View all »